; and (4) develop memoranda of agreement, joint funding agreements, and other cooperative arrangements necessary for meeting long-term challenges and achieving specific technical goals. (d) Report (1) In general Not later than December 31, 2020, the Secretary shall submit to the congressional defense committees a report on the program carried out under subsection (a). (2) Elements The report required by paragraph (1) shall include the following: (A) An assessment of the potential national security risks of emerging biotechnologies technologies. (B) An assessment of the efforts of foreign powers to use emerging biotechnologies for military applications and other purposes. (C) A description of the knowledge-base of the Department with respect to emerging biotechnologies, plans to defend against potential national security threats posed by emerging biotechnologies, and any plans of the Secretary to enhance such knowledge-base. (D) A plan that describes how the Secretary intends to use emerging biotechnologies for military applications and to meet other needs of the Department. (E) A description of activities undertaken consistent with this section, including funding for activities consistent with the section. (F) Such other matters as the Secretary considers appropriate. (3) Form The report submitted under paragraph (1) shall be submitted in unclassified form, but may include a classified annex. (e) Definition of emerging biotechnologies In this section, the term emerging biotechnologies includes the following: (1) Engineered biology, which is the application of engineering design principles and practices to biological, genetic, molecular, and cellular systems to enable novel functions and capabilities. (2) Neurotechnology, which refers to central and peripheral nervous system interfaces that leverage structural, computational, and mathematical modeling to develop devices that decode neural activity (identify how it corresponds to a particular behavior or cognitive state, such as sensorimotor function, memory, or